biote Corp. (BTMD) vs Clene Inc. (CLNN)
A side-by-side comparison of biote Corp. and Clene Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BTMD
biote Corp.
$1.12HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
CLNN
Clene Inc.
$3.91HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — BTMD vs CLNN
growth of $100 · dividends reinvested · last 5yBTMD -88.9% (-35.5%/yr)CLNN -97.9% (-54.0%/yr)BTMD compounded faster over this window
Log scale — wide-divergence pair
BTMD CLNN
BTMD vs CLNN: by the numbers
- •CLNN is the larger company ($50M vs $49M market cap).
- •BTMD is profitable (3.19% net margin) while CLNN runs a net loss (-20059.90%).
- •BTMD grew revenue faster over the past five years (10.52% vs -18.30% CAGR).
Metrics side by side
Valuation
| Metric | BTMD | CLNN |
|---|---|---|
| P/E ratio | 9.60 | N/A |
| P/S ratio | 0.27 | 253.62 |
| EV / EBITDA | 8.97 | N/A |
| FCF yield | 39.84% | N/A |
Profitability
| Metric | BTMD | CLNN |
|---|---|---|
| Gross margin | 71.46% | 78.50% |
| Operating margin | 18.50% | -11541.50% |
| Net margin | 3.19% | -20059.90% |
| ROIC | 13.63% | -109.13% |
Growth (annualized)
| Metric | BTMD | CLNN |
|---|---|---|
| Revenue CAGR (5Y) | 10.52% | -18.30% |
| EPS CAGR (5Y) | -25.90% | N/A |
| FCF CAGR (5Y) | 3.81% | N/A |
| Total return CAGR (5Y) | -35.12% | -51.16% |
Frequently asked
- Which has grown faster, BTMD or CLNN?
- Over the past five years, BTMD grew revenue faster — BTMD at a 10.52% CAGR versus CLNN at -18.30%.
- Is BTMD or CLNN more profitable?
- BTMD runs the higher net margin — BTMD at 3.19% versus CLNN at -20059.90%.
- How have BTMD and CLNN total returns compared?
- Over the past 5 years, BTMD delivered -35.12% and CLNN delivered -51.16% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
biote P/E ratiobiote ROEClene ROEbiote operating marginClene operating marginbiote revenue growthClene revenue growthbiote free cash flowClene free cash flow
biote & Clene appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.